A prolonged increase in proinflammatory cytokines is associated with osteoporotic and autoimmune bone loss and, conversely, anti‐inflammatory pathways are associated with protection against bone loss. Milk fat globule‐epidermal growth factor (MFG‐E)‐8 is a glycoprotein that is proresolving, regulates apoptotic cell clearance, and has been linked to autoimmune disease and skeletal homeostasis. The role of MFG‐E8 in the young vs. adult skeleton was determined in mice deficient in MFG‐E8 (KO). In vivo , trabecular bone was similar in MFG‐E8KO and wild‐type (WT) mice at 6 and 16 wk, whereas 22 wk adult MFG‐E8KO mice displayed significantly reduced trabecular BV/TV. The number of osteoclasts per bone surface was increased in 22‐wk MFG‐E8 KO vs. WT mice, and recombinant murine MFG‐E8 decreased the number and size of osteoclasts in vitro. Adult MFG‐E8KO spleen weight:body weight was increased compared with WT, and flow cytometric analysis showed significantly increased myeloid‐derived suppressor cells (CD11b hi GR‐1 + ) and neutrophils (CD11b hi Ly6G + ) in MFG‐E8KO bone marrow, suggesting an inflammatory phenotype. PTH‐treated MFG‐E8KO mice showed a greater anabolic response (+124% BV/TV) than observed in PTH‐treated WT mice (+64% BV/TV). These data give insight into the role of MFG‐E8 in the adult skeleton and suggest that anabolic PTH may be a valuable therapeutic approach for autoimmune‐associated skeletal disease.—Michalski, M. N., Seydel, A. L., Siismets, E. M., Zweifler, L. E., Koh, A. J., Sinder, B. P., Aguirre, J. I., Atabai, K., Roca, H., McCauley, L. K. Inflammatory bone loss associated with MFG‐E8 deficiency is rescued by teriparatide. FASEB J. 32, 3730–3741 (2018). www.fasebj.org